DAPAGLIFLOZIN
- Product NDC
- 62332-392
- 11-digit product format
- 623320392
- Labeler code
- 62332
- Product ID
- 62332-392_befb2492-ced0-4523-9051-6d766b2fdb69
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- DAPAGLIFLOZIN
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Alembic Pharmaceuticals Inc.
- Application
- ANDA211560
- Marketing category
- ANDA
- Marketing start
- 2026-04-06
- Substance
- DAPAGLIFLOZIN
- Active strength
- 5 mg/1
- Pharmacologic classes
- Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 1ULL0QJ8UC | DAPAGLIFLOZIN | 461432-26-8 | DAPAGLIFLOZIN |
Packages
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 62332-392-30 | 62332039230 | 30 TABLET, FILM COATED in 1 BOTTLE (62332-392-30) | 2026-04-06 | No | No | Historical |
| 62332-392-91 | 62332039291 | 1000 TABLET, FILM COATED in 1 BOTTLE (62332-392-91) | 2026-04-06 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| DAPAGLIFLOZIN | Alembic Pharmaceuticals Inc. | Alembic Pharmaceuticals Limited | 2026-04-07 | Human Prescription Drug Label | 11 |